| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |